Watanabe D, Morimoto S, Morishima N, Ichihara A
Endocrine. 2025; .
PMID: 39954166
DOI: 10.1007/s12020-025-04193-z.
You M, Lu Z, Wang B, Liu M, Zhou Q, Li L
PLoS One. 2025; 20(2):e0314943.
PMID: 39946402
PMC: 11824956.
DOI: 10.1371/journal.pone.0314943.
Duquet L, Lefebvre L, Lemaire-Paquette S, Malick M, Mallet P, St-Jean M
J Endocr Soc. 2025; 9(3):bvae209.
PMID: 39911522
PMC: 11795192.
DOI: 10.1210/jendso/bvae209.
Liu S, Wang X, Wang P
Hypertens Res. 2025; .
PMID: 39849050
DOI: 10.1038/s41440-025-02126-x.
Borozan S, Kamrul-Hasan A, Shetty S, Pappachan J
Curr Hypertens Rep. 2025; 27(1):8.
PMID: 39821533
PMC: 11739263.
DOI: 10.1007/s11906-025-01323-w.
A Case of Primary Aldosteronism Masquerading as Bartter and Gitelman Syndromes.
Hasini N, Gupta A, Priyadarshi A, Alam A, Quaiser S
Cureus. 2025; 16(12):e75644.
PMID: 39803142
PMC: 11725329.
DOI: 10.7759/cureus.75644.
Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate.
Jia M, Lin L, Yu H, Dong Z, Pan X, Song X
Sci Rep. 2025; 15(1):1690.
PMID: 39799159
PMC: 11724956.
DOI: 10.1038/s41598-025-85900-8.
E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production.
Chen L, Hu X, Wang G, Yu F, Dai Z, Jian X
Cell Mol Life Sci. 2024; 82(1):27.
PMID: 39725733
PMC: 11671668.
DOI: 10.1007/s00018-024-05545-0.
Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling.
Yi T, Lu D, Cui Y, Zhang Z, Yang X, Zhang J
Mol Imaging Biol. 2024; 27(1):142-150.
PMID: 39715984
PMC: 11805762.
DOI: 10.1007/s11307-024-01976-0.
Attenuation of Hypertension and protection of vascular inflammation in hyperaldosteronism: GPER1 as potential therapeutic candidate when MR antagonist is less satisfying?.
Lai Y, Tang Z, Du Z, Zeng Q, Xia Y, Chen S
Endocrine. 2024; 87(3):1276-1284.
PMID: 39565544
PMC: 11845544.
DOI: 10.1007/s12020-024-04106-6.
Exploration of the shared gene signatures and comorbidity mechanisms of primary aldosteronism and atrial fibrillation.
Wan J, Liu S, Luo T, Yang Y, Wang D, Wang X
Endocr Connect. 2024; 14(1.
PMID: 39475718
PMC: 11728919.
DOI: 10.1530/EC-24-0402.
Usefulness of the Upright Posture Test in the Diagnosis of Primary Aldosteronism.
Younes N, St-Jean M, Desrochers M, Therasse E, Latour M, Bourdeau I
J Endocr Soc. 2024; 8(10):bvae155.
PMID: 39301312
PMC: 11411212.
DOI: 10.1210/jendso/bvae155.
Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study.
Ji G, Yang C, Hou J, Zhou Y, Luo T, Yang Y
Hypertens Res. 2024; 48(1):200-211.
PMID: 39300300
DOI: 10.1038/s41440-024-01897-z.
Typing diagnostic value of Ga-pentixafor PET/CT for patients with primary aldosteronism and unilateral nodules.
Zuo R, Liu S, Ren X, Li W, Xia Z, Xu L
Endocrine. 2024; 87(1):314-324.
PMID: 39251468
DOI: 10.1007/s12020-024-04024-7.
Esaxerenone Attenuates Aldosterone-Induced Mitochondrial Damage-Mediated Pyroptosis in Mouse Aorta and Rat Vascular Smooth Muscle Cells.
Xian Y, Wang X, Chang Y, Qiang P, Han Y, Hao J
Life (Basel). 2024; 14(8).
PMID: 39202709
PMC: 11355590.
DOI: 10.3390/life14080967.
Rare correlation of somatic PRKACA mutations with pregnancy-associated aldosterone- and cortisol-producing adenomas: a case report and literature review.
Lin J, Li Y, Huang Z, Zhu Y, Li L, Yang H
BMC Endocr Disord. 2024; 24(1):116.
PMID: 39010034
PMC: 11251286.
DOI: 10.1186/s12902-024-01645-x.
Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.
Shah S, Libianto R, Gwini S, Rusell G, Young M, Fuller P
J Endocr Soc. 2024; 8(8):bvae113.
PMID: 38957654
PMC: 11215789.
DOI: 10.1210/jendso/bvae113.
Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism.
Yang J, McCarthy J, Shah S, Ng E, Shen J, Libianto R
J Endocr Soc. 2024; 8(7):bvae109.
PMID: 38887633
PMC: 11181003.
DOI: 10.1210/jendso/bvae109.
Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization.
Luo T, Wan J, Liu S, Wang X, Zhou P, Xue Q
Ir J Med Sci. 2024; 193(5):2269-2279.
PMID: 38856963
DOI: 10.1007/s11845-024-03730-5.
Insight into the status of plasma renin and aldosterone measurement: findings from 526 clinical laboratories in China.
Zhou W, Deng Y, Ma W, Zhao H, Wang K, Zhang Q
Clin Chem Lab Med. 2024; 62(11):2233-2241.
PMID: 38687473
DOI: 10.1515/cclm-2024-0373.